P

Inventor

HODGETTS KEVIN

US11 patents
⚠️ This page may combine multiple inventors who share the name “HODGETTS KEVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEUROGEN CORP

4 patents
US6420365B1Jul 16, 2002

Imidazopyridines and related derivatives as selective modulators of bradykinin B2 receptors

NEUROGEN CORP9 citations72
US6294530B1Sep 25, 2001

1-azatricyclic-4-benzylpiperazines

NEUROGEN CORP7 citations71
US6509366B2Jan 21, 2003

Substituted imidazoles as selective modulators of Bradykinin B2 receptors

NEUROGEN CORP7 citations62
US6403591B1Jun 11, 2002

1-azatricyclic-4-benzylpiperazines

NEUROGEN CORP0 citations50

UNIV INDIANA RES & TECH CORP

2 patents
US9895358B2Feb 20, 2018

Combination therapies for treatment of spinal muscular atrophy

UNIV INDIANA RES & TECH CORP11 citations80
US10420753B2Sep 24, 2019

Combination therapies for treatment of spinal muscular atrophy

UNIV INDIANA RES & TECH CORP0 citations48

OHIO STATE INNOVATION FOUNDATION

2 patents
US12286420B2Apr 29, 2025

EAAT2 activators and methods of using thereof

OHIO STATE INNOVATION FOUNDATION0 citations58
US11702403B2Jul 18, 2023

EAAT2 activators and methods of using thereof

OHIO STATE INNOVATION FOUNDATION0 citations58

BRIGHAM & WOMENS HOSPITAL INC

2 patents
US11377436B2Jul 5, 2022

EAAT2 enhancing molecules

BRIGHAM & WOMENS HOSPITAL INC0 citations47
US10787433B2Sep 29, 2020

Pyridazine derivatives as EAAT2 activators

BRIGHAM & WOMENS HOSPITAL INC0 citations37

IHLE DAVID C

1 patent
US8580812B2Nov 12, 2013

Heteroaryl amide analogues as P2X7 antagonists

IHLE DAVID C9 citations77